The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology
Julia Obergasteiger(Institute for Biomedicine), Mattia Volta(Eurac Research)
Cited by 25
Related Papers
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin<scp>FQ</scp>receptor antagonist<scp>NiK</scp>‐21273 in comparison with<scp>SB</scp>‐612111
|British Journal of Pharmacology|2012|28
RIT2 reduces LRRK2 kinase activity and protects against alpha-synuclein neuropathology
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2